GHK and Basal Keratinocytes: What the p63 and Integrin Studies Show
Skin-equivalent studies report that copper-GHK and copper-free GHK raised p63, PCNA and integrins in basal keratinocytes. What was measured, and its limits.
Skin-equivalent studies report that copper-GHK and copper-free GHK raised p63, PCNA and integrins in basal keratinocytes. What was measured, and its limits.
GHK and GHK-Cu coated silver particles stopped bacteria at 8 ug/ml, near their cell-toxic dose. What two papers show, and why silver is the active part.
A needle-free jet pushed a five-ingredient mix with copper-GHK into skin. A one-patient case and a small melasma series show what they can and can’t say.
QR678 hair injections combine copper tripeptide-1 with five other factors. What the 1000-patient pilot and mouse work show, and what they can’t.
A 2023 study gave copper-free GHK to 15-month-old mice before sleep deprivation. What changed on the maze and in the brain, and what it can’t say.
A 2025 open-label study of a four-ingredient copper tripeptide gel in 30 women with acne scars: the scar scores, a roughness figure that fails.
Three studies show GHK can trap toxic lipid-peroxidation aldehydes and some radicals in buffer and cells. The doses, limits and copper caveat.
A 2024 open-label study of a scrub, copper tripeptide serum and shampoo cut flaking 61% in 15 days. What it measured and what it cannot show.
Two rat studies injected copper-free GHK around a brain bleed. What was given when, how many animals, and why it is not evidence for GHK-Cu.
The 1994 Iamin Gel trial of GHK-Cu in diabetic foot ulcers: what the abstract reports, what it omits, and why two 2026 reviews skipped it.
The anti-anxiety claim for GHK-Cu traces to reviews. When a 2025 study put GHK through a validated anxiety test, it showed no anxiolytic effect.
GHK-Cu turns up in antimicrobial wound research, but the bacteria-killing is done by copper ions, modified analogues, or another agent in the dressing.